Literature DB >> 29880626

Campylobacter jejuni and Pseudomonas coinfection in the setting of ulcerative colitis.

John Paul Iguidbashian1, Jai D Parekh2, Shweta Kukrety2, Venkata Giri Andukuri2.   

Abstract

A 66-year-old woman presented with 2 days of fever and severe diarrhoea. She has a history of ulcerative colitis (UC), well controlled with medication. She also has a history of Ehlers-Danlos syndrome, infective endocarditis following aortic valve replacement and pulmonary embolism. She had complained of passing stool with traces of blood about 30 times per day. Stool testing for Clostridium difficile, routine culture and microscopy was done. She was started on ceftriaxone. CT scan revealed thick-walled colon consistent with UC flare. Flexible sigmoidoscopy showed active continuous colitis extending from the rectum to the proximal descending colon. Campylobacter jejuni was isolated from the stool and blood cultures yielded Pseudomonas aeruginosa. The antibiotic was transitioned to intravenous piperacillin/tazobactam and azithromycin followed by 2 weeks of intravenous cefepime. Her diarrhoea was controlled, and she was discharged for follow-up in 2 months. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  gastroenterology; infection (gastroenterology); inflammatory bowel disease; ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 29880626      PMCID: PMC6011532          DOI: 10.1136/bcr-2018-224941

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  The polymicrobial Actinomyces naeslundii and Pseudomonas aeruginosa sepsis in a patient with ulcerative colitis 2 months after colonoscopy.

Authors:  Mirjana Balen Topić; Boško Desnica; Ninoslava Vicković; Tomislava Skuhala; Kristijan Bayer; Suzana Bukovski
Journal:  Wien Klin Wochenschr       Date:  2013-12-03       Impact factor: 1.704

Review 2.  A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease?

Authors:  Lisa D Kalischuk; Andre G Buret
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-29       Impact factor: 4.052

3.  Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis.

Authors:  Daniel Siegal; Fathima Syed; Naveed Hamid; Burke A Cunha
Journal:  Heart Lung       Date:  2005 Jul-Aug       Impact factor: 2.210

4.  Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study.

Authors:  Triana Lobatón; Ilse Hoffman; Severine Vermeire; Marc Ferrante; Jan Verhaegen; Gert Van Assche
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

5.  Survival of Campylobacter jejuni under conditions of atmospheric oxygen tension with the support of Pseudomonas spp.

Authors:  Friederike Hilbert; Manuela Scherwitzel; Peter Paulsen; Michael P Szostak
Journal:  Appl Environ Microbiol       Date:  2010-07-16       Impact factor: 4.792

6.  Ulcerative colitis with multidrug-resistant Pseudomonas aeruginosa infection successfully treated with bifidobacterium.

Authors:  Azusa Nagasaki; Hirokazu Takahashi; Mizue Iinuma; Takashi Uchiyama; Seitaro Watanabe; Tomoko Koide; Chikako Tokoro; Masahiko Inamori; Yasunobu Abe; Atsushi Nakajima
Journal:  Digestion       Date:  2010-01-19       Impact factor: 3.216

7.  Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease.

Authors:  C Quondamcarlo; G Valentini; M Ruggeri; G Forlini; P Fenderico; Z Rossi
Journal:  Tech Coloproctol       Date:  2003-10       Impact factor: 3.781

8.  Risk factors and clinical implication of superimposed Campylobacter jejuni infection in patients with underlying ulcerative colitis.

Authors:  Zubin Arora; Saurabh Mukewar; Xianrui Wu; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-07-08
  8 in total
  1 in total

Review 1.  Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.

Authors:  Junfeng Zou; Chen Liu; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.